当前位置：药药网 / 药品 / 美国NDC未完成药物数据库文件(本栏目更新到2026-3-31)
药品名称： 商品名称： 药品NDC： 上市日期： -格式:2020-5-3
注册申请号： 市场分类： 活性成分： 持证企业：
 美国NDC未完成药物数据库文件21130条(本栏目更新到2026-3-31)
药品名称(分析)
商品名
药品NDC
专利人(分析)
上市日期
活性成分
市场分类
规格(分析)
申请号
Topiramate
DRUG FOR FURTHER PROCESSING
0480-2357
Teva Pharmaceuticals, Inc.
20230310
TOPIRAMATE
DRUG FOR FURTHER PROCESSING
50
0480-2357_90f5abdf-e78f-4e20-9a94-665c4808924e
Topiramate
DRUG FOR FURTHER PROCESSING
0480-2358
Teva Pharmaceuticals, Inc.
20230310
TOPIRAMATE
DRUG FOR FURTHER PROCESSING
100
0480-2358_90f5abdf-e78f-4e20-9a94-665c4808924e
Topiramate
DRUG FOR FURTHER PROCESSING
0480-2359
Teva Pharmaceuticals, Inc.
20230310
TOPIRAMATE
DRUG FOR FURTHER PROCESSING
200
0480-2359_90f5abdf-e78f-4e20-9a94-665c4808924e
Phentermine and topiramate
DRUG FOR FURTHER PROCESSING
0480-3295
Teva Pharmaceuticals, Inc.
20241106
PHENTERMINE HYDROCHLORIDE; TOPIRAMATE
DRUG FOR FURTHER PROCESSING
15; 92
0480-3295_70f0d924-c69c-4734-b781-77fe21d9e869
Phentermine and topiramate
DRUG FOR FURTHER PROCESSING
0480-3296
Teva Pharmaceuticals, Inc.
20241106
PHENTERMINE HYDROCHLORIDE; TOPIRAMATE
DRUG FOR FURTHER PROCESSING
7.5; 46
0480-3296_70f0d924-c69c-4734-b781-77fe21d9e869
Phentermine and topiramate
DRUG FOR FURTHER PROCESSING
0480-3297
Teva Pharmaceuticals, Inc.
20241106
PHENTERMINE HYDROCHLORIDE; TOPIRAMATE
DRUG FOR FURTHER PROCESSING
3.75; 23
0480-3297_70f0d924-c69c-4734-b781-77fe21d9e869
Gabapentin
DRUG FOR FURTHER PROCESSING
0480-3494
Teva Pharmaceuticals, Inc.
20250804
GABAPENTIN
DRUG FOR FURTHER PROCESSING
100
0480-3494_1f529460-bfed-4f2a-bc85-16b535364aa5
Gabapentin
DRUG FOR FURTHER PROCESSING
0480-3495
Teva Pharmaceuticals, Inc.
20250804
GABAPENTIN
DRUG FOR FURTHER PROCESSING
300
0480-3495_1f529460-bfed-4f2a-bc85-16b535364aa5
Gabapentin
DRUG FOR FURTHER PROCESSING
0480-3496
Teva Pharmaceuticals, Inc.
20250804
GABAPENTIN
DRUG FOR FURTHER PROCESSING
400
0480-3496_1f529460-bfed-4f2a-bc85-16b535364aa5
Pirfenidone
DRUG FOR FURTHER PROCESSING
0480-3610
Teva Pharmaceuticals, Inc.
20220511
PIRFENIDONE
DRUG FOR FURTHER PROCESSING
267
0480-3610_d4e406e1-3dae-41ea-98e6-521626370a69
Pirfenidone
DRUG FOR FURTHER PROCESSING
0480-3611
Teva Pharmaceuticals, Inc.
20220511
PIRFENIDONE
DRUG FOR FURTHER PROCESSING
801
0480-3611_d4e406e1-3dae-41ea-98e6-521626370a69
Tasimelteon
DRUG FOR FURTHER PROCESSING
0480-4490
Teva Pharmaceuticals, Inc.
20230530
TASIMELTEON
DRUG FOR FURTHER PROCESSING
20
0480-4490_066cf6d6-da45-451d-ad2b-3b6203e2c10c
Propylthiouracil
DRUG FOR FURTHER PROCESSING
0480-9242
Teva Pharmaceuticals, Inc.
20231027
PROPYLTHIOURACIL
DRUG FOR FURTHER PROCESSING
50
0480-9242_2f1571a0-a7c1-4218-9330-a8cc3af347e0
Amiloride Hydrochloride and Hydrochlorothiazide
DRUG FOR FURTHER PROCESSING
0555-0483
Teva Pharmaceuticals USA, Inc.
20230524
AMILORIDE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE
DRUG FOR FURTHER PROCESSING
5; 50
0555-0483_439d9e87-b105-432f-9d2e-097f313e6882
Leucovorin Calcium
DRUG FOR FURTHER PROCESSING
0555-0484
Teva Pharmaceuticals USA, Inc.
20210610
LEUCOVORIN CALCIUM
DRUG FOR FURTHER PROCESSING
5
0555-0484_7c293404-cb7f-477e-ae80-78aeb3f5f267
Leucovorin Calcium
DRUG FOR FURTHER PROCESSING
0555-0485
Teva Pharmaceuticals USA, Inc.
20210610
LEUCOVORIN CALCIUM
DRUG FOR FURTHER PROCESSING
25
0555-0485_7c293404-cb7f-477e-ae80-78aeb3f5f267
esomeprazole magnesium
DRUG FOR FURTHER PROCESSING
0573-2453
Haleon US Holdings LLC
20180126
ESOMEPRAZOLE MAGNESIUM TRIHYDRATE
DRUG FOR FURTHER PROCESSING
20
0573-2453_5259d762-4075-4452-8e55-95345915f764
Verapamil Hydrochloride
DRUG FOR FURTHER PROCESSING
0591-0343
Actavis Pharma, Inc.
19861001
VERAPAMIL HYDROCHLORIDE
DRUG FOR FURTHER PROCESSING
80
0591-0343_97a44eae-e889-48d9-8973-631bb2a247fa
Verapamil Hydrochloride
DRUG FOR FURTHER PROCESSING
0591-0345
Actavis Pharma, Inc.
19861001
VERAPAMIL HYDROCHLORIDE
DRUG FOR FURTHER PROCESSING
120
0591-0345_97a44eae-e889-48d9-8973-631bb2a247fa
Hydrochlorothiazide
DRUG FOR FURTHER PROCESSING
0591-0347
Actavis Pharma, Inc.
19961227
HYDROCHLOROTHIAZIDE
DRUG FOR FURTHER PROCESSING
12.5
0591-0347_a662ae5a-ebcc-459e-ab98-53183ed64ded
网站地图 - 网站开发 - 网站简介 - 会员服务 - 法律声明 - 联系我们 - 药品招商频道 - 药品信息排行 - 2018年版国家基本药物目录 - 意见反馈
免责声明：以上所展示的信息由企业自行提供，内容的真实性、准确性和合法性由发布企业负责，医药网对此不承担任何责任。
相关链接：医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究　　客服热线：0575-83552251 / 13754370441  QQ客服：药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证：浙B2-20220931　互联网药品信息服务资格证书编号：(浙)-经营性2023-0215　浙公网安备:330683240604819103159
　医药代理商群１：药药网药品采购交流医药代理商群２：药药网药品采购交流2医药代理商群３：药药网药品采购交流3